CVRx, Inc. (NASDAQ: CVRX) ('CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...

The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a ...

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...

The center uses the claims submission technology to automatically turn its clinical information into data appropriate for ...

Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue ...

The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033. Market growth is underpinned by a rapidly expanding AFib patient population, ...

What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...

Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.

CPT I code for NanoKnife prostate procedures is set to take effect on January 1, with management expecting incremental, ...

Cardiovascular imaging, which continues to evolve alongside interventions and other technologies, made notable strides in the ...

Discover the TongYi Fun-Audio-Chat speech-to-speech model by Alibaba Group. Explore how this Large Audio Language Model ...

As the health care delivery landscape continues to evolve, the need to advocate for policies that affect patients and the ...